Literature DB >> 15827808

Desmoplastic melanoma: a heterogeneous entity in which subclassification as "pure" or "mixed" may have important prognostic significance.

Richard A Scolyer, John F Thompson.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15827808     DOI： 10.1245/ASO.2005.12.914

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  7 in total

Review 1.  Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care.

Authors:  Richard A Scolyer; Georgina V Long; John F Thompson
Journal:  Mol Oncol       Date:  2011-03-21       Impact factor: 6.603

2.  Pitfalls and important issues in the pathologic diagnosis of melanocytic tumors.

Authors:  Stanley W McCarthy; Richard A Scolyer
Journal:  Ochsner J       Date:  2010

Review 3.  Nasal Mucosal Desmoplastic Melanoma: A Case Report with Review of the Literature.

Authors:  Carlos A Ortega; Madelyn N Stevens; James S Lewis; Michael C Topf
Journal:  Head Neck Pathol       Date:  2022-03-07

4.  An unusual case of desmoplastic malignant melanoma.

Authors:  Pandiaraja Javabal; Viswanathan Subramanian
Journal:  J Cutan Aesthet Surg       Date:  2015 Jan-Mar

5.  Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).

Authors:  Richard A Scolyer; Meagan J Judge; Alan Evans; David P Frishberg; Victor G Prieto; John F Thompson; Martin J Trotter; Maureen Y Walsh; Noreen M G Walsh; David W Ellis
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

Review 6.  Melanoma pathology: new approaches and classification.

Authors:  I Yeh; B C Bastian
Journal:  Br J Dermatol       Date:  2021-05-31       Impact factor: 11.113

7.  Evolution of superficial spreading melanoma to resemble desmoplastic melanoma: case report.

Authors:  Martin G Cook; Barry W E M Powell; Megan E Grant; Adele C Green
Journal:  Virchows Arch       Date:  2021-07-20       Impact factor: 4.064
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.